Brief: Silence Therapeutics To Be Acquired By Merck KGaA
Mon 13:59
BRIEF-Silence Therapeutics To Be Acquired By Merck KGaA Oct 19 (Reuters) - Silence Therapeutics PLC SLNCF.PK:
ENTERS INTO AGREEMENT TO BE ACQUIRED BY MERCK KGAA, DARMSTADT, GERMANY
ALL-CASH DEAL VALUES SILENCE THERAPEUTICS AT ABOUT $1.30 BILLION
ENTERS AGREEMENT TO BE BOUGHT BY MERCK KGAA, DARMSTADT, GERMANY
PRICE OF $20 PER ADS IN CASH
DEAL ENTERPRISE VALUE OF $1.10 BILLION
SHAREHOLDERS TO RECEIVE $20 PER ADS OR $6.67 PER ORDINARY SHARE
SECURITYHOLDERS WITH 14% VOTING POWER ENTER VOTING AND SUPPORT AGREEMENT
Source text: ID:nBwqs8wda
Further company coverage: SLNCF.PK
((Reutersbriefs@thomsonreuters.com;))